Table 4 Risk of severe RSD development according to SGA status.
Sever RDS (yes vs. no) | ||||
|---|---|---|---|---|
Non-SGA | SGA | |||
aOR (95%CI) | p value | aOR (95%CI) | p value | |
Preeclampsia (yes vs. no) | 1.15 (0.95–1.40) | 0.142 | 1.12 (0.94–1.34) | 0.218 |
GA | 0.72 (0.69–0.76) | <0.001 | 0.62 (0.58–0.66) | <0.001 |
BBW (per 100 grams) | 0.93 (0.89–0.97) | 0.001 | 0.92 (0.87–0.97) | 0.004 |
Gender (male vs. female) | 1.27 (1.16–1.40) | <0.001 | 1.23 (1.03–1.47) | 0.024 |
Antenatal steroid using (≥2 vs.<2) | 0.55 (0.50–0.60) | <0.001 | 0.61 (0.51–0.73) | <0.001 |